v1
Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer.
Identifier:nobleid.org/w1/20260515/2AAAF802
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/2AAAF802)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →